丙酮酸激酶同工酶2(PKM2)在肿瘤发生中的作用和机制

基本信息
批准号:81572463
项目类别:面上项目
资助金额:65.00
负责人:张宏冰
学科分类:
依托单位:中国医学科学院基础医学研究所
批准年份:2015
结题年份:2019
起止时间:2016-01-01 - 2019-12-31
项目状态: 已结题
项目参与者:黄富强,张海红,陈虹宇
关键词:
mTOR动物模型有氧糖酵解肿瘤丙酮酸激酶2
结项摘要

Aerobic glycolysis (Warburg effect) promotes the use of glucose for biosynthetic pathways necessary for cell proliferation and tumor growth. Overexpression of the M2 isoform of glycolytic enzyme pyruvate kinase (PKM2) is found in various tumors. Studies using in vitro culture systems and xenografting tumors in immunodeficient nude mice revealed the critical role of PKM2 in both aerobic glycolysis and anabolic metabolism as well as enhancement of tumor development in cancer cells. However, knockout of PKM2 accelerated but not diminished tumorigenesis in mice, implicating PKM2 in tumor suppression. To resolve the controversy over those reported conflicting roles of PKM2 in tumor development, we mimicked the overexpression of PKM2 in human tumors by knocking-in PKM2 gene in mice (Pkm2-KI). Spontaneous tumors were formed with low frequency in multiple organs of Pkm2-KI mice control mice while no tumors were found in control mice. Long-term observation of expanded colonies will be applied to ascertain the incidence and tumor types in Pkm2-KI mice. As tumorigenesis is a multiple-step pathological process, Diethylnitrosamine and Azoxymethane will be used to induce mouse liver cancer and colon cancer, respectively, in the presence (Pkm2-KI) or absence (control) of PKM2 overexpession. The impact of PKM2 on carcinogen-induced carcinogenesis will thus help us determine the role of PKM2 in tumor development. mRNA array and metabolic profiling of non-tumor and tumor tissues with or without overexpressed PKM2 will be taken for dissection of potential effectors of PKM2 in tumorigenesis. Characterization of these effectors may yield putative targets for cancer treatment.

有氧糖酵解(Warburg效应) 通过消耗大量葡萄糖,供给细胞快速增殖所需底物,促进肿瘤发展。糖酵解关键酶丙酮酸激酶同工酶2(PKM2)在人肿瘤组织高表达,通过体外细胞培养及裸鼠移植瘤等实验,发现 PKM2促进Warburg效应和肿瘤发展。可是,体内敲除Pkm2不是降低而是促进小鼠肿瘤的发展,为了澄清PKM2促进肿瘤还是抑制肿瘤,我们构建了PKM2基因敲入小鼠(Pkm2-KI),模拟临床肿瘤PKM2高表达, Pkm2-KI小鼠在多个器官低频率自发肿瘤,提示体内过表达PKM2可能促进肿瘤的发生。本研究将长期大样本观察Pkm2-KI小鼠自发肿瘤情况,分别用二乙基亚硝胺和氧化偶氮甲烷诱导Pkm2-KI和对照小鼠产生肝癌、结肠癌,确定PKM2高表达在化学诱导肿瘤发生中的作用,并通过检测组织mRNA表达谱及糖代谢谱,发现关键效应分子,阐明PKM2的作用机制,为肿瘤的发生和靶向治疗提供新的思路和策略。

项目摘要

肿瘤细胞倾向于利用有氧糖酵解(Warburg效应)满足其快速生长增殖的物质和能量需要。丙酮酸激酶(PKM)是催化糖酵解反应的限速酶之一,包括PKL,PKR,PKM1和PKM2四种同工酶,其中PKM2在人肿瘤组织高表达。通过体外细胞培养及裸鼠移植瘤等实验,发现 PKM2促进Warburg效应和肿瘤发展。可是,体内敲除Pkm2不是降低而是促进小鼠肿瘤的发展,为了澄清PKM2促进肿瘤还是抑制肿瘤,我们构建了PKM2基因敲入小鼠(Pkm2-KI),模拟临床肿瘤PKM2高表达。长期观察发现Pkm2-KI小鼠全身多器官低频率自发肿瘤,包括肾,肠和乳腺,提示体内过表达PKM2可能促进肿瘤的发生。根据人肝细胞肝癌(HCC)临床样本中PKM2高表达的现象,我们用二乙基亚硝胺(DEN))诱导小鼠HCC模型,以研究PKM2高表达在HCC中的作用。结果发现PKM2高表达促进DEN 诱导的肝脏肿瘤的发生发展。为阐明PKM2的作用机制,我们构建了PKM2过表达的小鼠胚胎成纤维细胞(MEF),发现PKM2过表达加速了MEF细胞的生长增殖,增强了细胞的糖酵解和线粒体呼吸能力。本研究阐明了PKM2过表达促进肝癌发生,为肿瘤的发生和靶向治疗提供新的思路和策略。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
3

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017
4

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

DOI:10.2147/DDDT.S163951
发表时间:2018
5

IRE1-RACK1 axis orchestrates ER stress preconditioning-elicited cytoprotection from ischemia/reperfusion injury in liver

IRE1-RACK1 axis orchestrates ER stress preconditioning-elicited cytoprotection from ischemia/reperfusion injury in liver

DOI:
发表时间:2016

张宏冰的其他基金

相似国自然基金

1

丙酮酸激酶同工酶2(PKM2)在心肌肥厚中的作用及其机制研究

批准号:81873499
批准年份:2018
负责人:李俊明
学科分类:H0207
资助金额:25.00
项目类别:面上项目
2

丙酮酸激酶PKM2调控椎间盘退变的机制研究

批准号:81572181
批准年份:2015
负责人:王善金
学科分类:H0608
资助金额:51.00
项目类别:面上项目
3

Aurora-A激酶结合丙酮酸激酶PKM2协调分裂期进程和能量代谢的机理研究

批准号:31571396
批准年份:2015
负责人:杨振业
学科分类:C0703
资助金额:65.00
项目类别:面上项目
4

6磷酸果糖激酶2同工酶3(PFKFB3)介导细胞周期调控机制及其在肿瘤发生中作用的研究

批准号:81874055
批准年份:2018
负责人:王霆
学科分类:H1808
资助金额:63.00
项目类别:面上项目